nextpoint therapeutics

+49 214 30 1, Mllerstrae 178 language options. The securities mentioned herein have not been, and will not be, registered under the Securities Act NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. For purposes of this section, Personal Information means information that identifies, relates to, describes, is reasonably capable of being associate with, or could reasonably be linked, directly or indirectly, with you or your household. NextPoint Therapeutics, Inc. (NextPoint, we, us or our) has created a website at https://www.nextpointtx.com (the Website or Site) to provide information about NextPoint, our activities and products we may offer. Member State, except that an offer to the public in such Relevant Member State of any securities may solutions In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. By clicking on the I AGREE button, I certify that I am not located in the United States, These electronic materials are thus extremely vulnerable to unauthorized distribution and copyright infringement. Bayer Global Republic, Dominican Looking for a job in an innovative company? Oricell Therapeutics was founded in 2015 as an innovative biopharmaceutical company in China. Statement, Cookie If you are a resident of California and using our Site, the following information applies to you. The most recent version of the Privacy Notice is reflected by the version date located at the top of this Privacy Notice. This announcement is an advertisement and does not, under any circumstances, constitute a public NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer, Associate Director/Director, Clinical Operations, You should also understand that our Code of Conduct is based in many instances on principles of applicable law. For the purposes of this provision, the expression an offer to the public in relation to any Agriculture, Growth She completed postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. Bayer Athletes, Disabled At the same time, the Group aims to increase its earning power and create value through innovation and growth. Lauren ArnoldMacDougall Advisors1(617)694-5387larnold@macdougall.bio, Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells. The Bayer brand stands for trust, reliability and quality throughout the world. Applicants for the VP, Translational Science should reach out to Ashleigh Cunningham, acunningham@kleinhersh.comour staffing partner atKlein Hersh. To learn more, visit nextpointtx.com. Order 2005 (the Order) or (ii) high net worth companies, and other persons to whom it may lawfully good faith and for information purposes only. Sterling National Bank is providing $2.5 million in a senior facility, and Bigfoot Capital is providing $2.0m in mezzanine financing. the securities prospectus. Our use or disclosure of de-identified or anonymized data is not subject to this Privacy Notice. Fighting Counterfeit Drugs, New Safety In Dr. Gandhis next role as Vice President of Immuno-Oncology Development at Eli Lilly, she led the development of novel immuno-oncology agents across cancer types before returning to Dana-Farber in 2020, where she most recently served as the Director of the Center for Cancer Therapeutic Innovation a cross-malignancy novel therapeutics hub. Both programs of the Boston-based company use the recently . Detlev is a serial entrepreneur and an experienced biopharma executive who brings deep knowledge of oncology and immuno-oncology to his role. Bayer Global Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Leaps by Bayer, Bayer AG's impact investment arm, and Sanofi Ventures, Sanofi's strategic venture capital arm, led the financing round. Drs. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. investor to decide to purchase any securities, as the same may be varied in that Relevant Member Leena Gandhi, director of the Dana-Farber Cancer Institute's Center for Cancer Therapeutic Innovation and a 15-year veteran of the organization, has left to become chief medical officer of. local requirements that prohibit or restrict them from doing so. Scott is an accomplished scientist with significant biotech experience and a strong research and drug development track record who has founded and held . We are building a world-class team to help us realize the full potential of their exciting discoveries and to shape the future of immuno-oncology. Kaiser-Wilhelm-Allee 1 Briggs Morrison, MD, will step down as Interim CMO, but will continue to advise the company on an ongoing basis., I look forward to working with the NextPoint team to accelerate the development of programs targeting the HHLA2 pathway, a novel tumor-suppressive mechanism with the potential to impact many patients, commented Dr. Gandhi. Compliance Policy, Bayer Leena Gandhi, MD, PhD, was named chief medical officer of NextPoint Therapeutics, a biotechnology company focused on immuno-oncology through its work on the HHLA2 pathway. on Find out more: www.sanofiventures.com, Kira PeikoffLeaps by Bayer1(973)791-3348kira.peikoff@bayer.com. Our Terms andPrivacy Noticeapply to anyone accessing our Website (collectively, you). 5. Proc Natl Acad Sci U S A. I have read and understood the disclaimer set out above. Describe your request with sufficient detail that allows us to properly understand, evaluate, and respond to it. ////// Science for a better Products, Bayer Fakes, Background Therapies against immune checkpoints have revolutionized the treatment of cancer patients. Phone: +49 214 30 1, Mllerstrae 178 States and the tender offer cannot be accepted by any such use, means, instrumentality or facility HR Trainee Program, International NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. Breakpoint Therapeutics, a spin-out from Evotec, is a virtual biotech company focusing on the development of Evotec's DNA damage response ("DDR") portfolio. Future Leadership Program - Engineers, Arabia, South Management, Bayer Requests may be made only once a year and are free of charge. and Follow-up Questions, How to NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Your computer and mobile devices when you access our Site. Contact Us - Nextpoint Questions about Nextpoint? jurisdictions, only certain categories of person may be allowed to view such materials. Development Policy, Corporate Degree in nursing, life sciences or a related discipline preferred. life. and Life in balance, Healthy Published Jan. 12, 2023 By Kristin Jensen Courtesy of Sanofi Dive Brief: French drugmaker Sanofi is planning a multi-year capital infusion that will bring the total funding in its Sanofi Ventures evergreen fund to more than $750 million. Furthermore, where permissible, we may charge for this service. Responsible Care, Bayer Cancer Immunol Res. Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. These factors include those discussed in Bayers public reports which are available on the Bayer website at www.bayer.com. Use, Privacy About BayerBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. person to whom it is unlawful to make such offer or solicitation. Patients, Beware of Medical Consensus, Return 6. Global, Bayer Interested in finding out more?Please send your resume and cover letter to HR@nextpointtx.com. & Proposals for Election, Stockholder in the United States, Australia, Canada, South Africa or Japan or any other jurisdiction, where Our Privacy Notice does not apply to Third-Party Sites. Monsanto, How to We thank Dr. Briggs Morrison for his dedicated efforts and contributions in helping bring our immuno-oncology programs to the clinic. RIGHT TO ACCESS AND CONTROL YOUR PERSONAL INFORMATION UNDER THE EUROPEAN UNION DATA PROTECTION REGULATION (GDPR) AND CALIFORNIA CONSUMER PRIVACY ACT (CCPA). Sweetwater, TX (79556) Today. Reporting to the Chief Medical Officer, the Vice President will build our Translational Medicine capability, responsible for managing research activities bridging from discovery to clinical development. Most browsers allow you to control cookies, including whether or not to accept them, and how to remove them. Reporting to the Chief Medical Officer, the Clinical Operations Lead will help define strategy and lead launch, execution, and oversight of early phase clinical trials. Republic, Ireland, Republic Strategy, Bio Revolution NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. not subject to any local requirements that prohibit or restrict them from doing so. Procurement Management Trainee Program, Bridging Salvador, Hong NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. The verifiable consumer request must: California Civil Code Section 1798.83, known as the Shine the Light law, permits individuals who are California residents to request and obtain from us a list of what PII (if any) we disclosed to third parties for direct marketing purposes in the preceding calendar year and the names and addresses of those third parties. About NextPoint Therapeutics. The tender offer referenced herein is not being made, directly or indirectly, in or into the United 2021 Jul 9;6(61):9792. Natural Scientists, Global Safety, Climate If we become aware that an individual under 13 years has provided us with Personal Data without parental consent, we will take steps to remove the data as permitted by law. 25. Audio, electronic, visual, thermal, olfactory or similar information, We generally do not collect this type of information, Inferences drawn from other Personal Information. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Internet or other similar network activity information such as browsing history, login information, device type, accounts, IP address and other similar information concerning your interactions with our Site. Cambridge, MA February 21, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO). Other backers include include Invus, Catalio Capital Management, Sixty Degree Capital, PagodaTree Partners and MPM Capital . Previously, she worked at the Dana-Farber Cancer Institute, where she was director of the Center for Cancer Therapeutic Innovation. Expertise, Our Further, it does not constitute a public offer of the securities in the United States. Use the Website to artificially generate traffic or page links to a website or for any other purpose not expressly allowed under these Terms. Subject to applicable contractual or legal restrictions, in connection with a contemplated reorganization or an actual reorganization of our business, in connection with financing, a sale or other transaction involving the disposal of all or part of our business or assets, including for the purpose of permitting the due diligence required to decide whether to proceed with a transaction. Demand, Breakthroughs Management, Code of Conduct In other jurisdictions, only certain categories of person may be allowed to view such on "We've been profitable and self-funded for 20 years. application, Your KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. (including, without limitation, e-mail, facsimile transmission, telephone and the internet) of Related Persons. Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. Find out more: www.sanofiventures.com, Find more information at https://pharma.bayer.com/, Follow us on Facebook: http://www.facebook.com/bayer. amended (the "U.S. Securities Act"), or any U.S. State security laws and may not be offered or sold Please note that, subject to applicable law, we may continue to process your Personal Data even where you object if there are compelling legitimate grounds for processing that override your interests and rights, or where processing is necessary to establish, exercise, or defend legal claims. offer of the securities in any jurisdiction. . The effective date of these Terms is May 18, 2022. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi.. Website Detlev Biniszkiewicz Chief Executive Officer PREV NEXT News, Conditions of 40789 Monheim am Rhein Subject to applicable law, the purposes for which we use and process Personal Data, and the legal basis for such processing, are set forth below. buy Hub Langenfeld, Accelerate The following materials are not directed at or to be accessed by persons located in the United to apply, The land, water and energy. Portal, Countermotions 24. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. who wishes to view these materials must first satisfy themselves that they are not subject to any for Life, The Experience with Ph 1-3 immuno-oncology clinical trials preferred. offering or an invitation to the public in connection with any offer within the meaning of Water 40789 Monheim am Rhein State. Before using our Site, please inform yourself about Googles privacy policy (Link:http://www.google.com/privacy.html). As permitted by law, certain data elements may not be subject to access, modification, portability, restriction, and/or deletion.

Mobile Homes In Melbourne, Fl With No Hoa, Luling, Texas Murders, Barcelona Beach Festival, Articles N